The announcement was made by the Federal Medical and Biological Agency (FMBA) of Russia, with its head Veronika Skvortsova confirming that the vaccine had successfully completed preclinical studies and was now ready for clinical use.
100% efficacy in…
Russia’s Enteromix Cancer Vaccine Shows 100% Success in Trial, Awaits Final Nod for Public Use
